Escalier

News

Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its pipeline.

News

Gilead/MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral suppression in phase 3, setting up regulatory filings.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.